Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 5/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.58 |
| ▸ | CRHBP | P24387 | 1/20 | 0.56 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 6/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | F2 | P00734 | 1/20 | 0.53 |
| ▸ | PLAU | P00749 | 1/20 | 0.53 |
| ▸ | ELANE | P08246 | 1/20 | 0.53 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13949537 | 0.87 | MAPT (0.53) | KDM4EMAPTCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL16628148 | 0.86 | KMT2A (0.64) | KDM4EMAPTCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL31504019 | 0.85 | KDM4E (0.72) | KDM4EMAPTFFAR1CRHBPCRHR2 | |
| SCHEMBL27807422 | 0.84 | KDM4E (0.71) | KDM4EFFAR1CRHBPCRHR2MEN1 | |
| SCHEMBL8737053 | 0.84 | MEN1 (0.60) | MAPTCYP2C9MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL23174919 | 0.83 | MAPT (0.51) | KDM4EMAPTCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL29730585 | 0.83 | MAPT (0.51) | KDM4EMAPTCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL9938318 | 0.83 | MEN1 (0.70) | MAPTCYP2C9CRHBPCRHR2MEN1 | |
| SCHEMBL930833 | 0.82 | MEN1 (0.62) | MAPTCYP2C9MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL3388760 | 0.82 | NPC1 (0.62) | MAPTCYP1A2CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9106057-B2 | White-emitting monomolecular compound using excited-state intramolecular proton transfer, organic electroluminescent element and laser device using the same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2015-08-11 | — | — | US | disclosed |
| US-9106057-B2 | White-emitting monomolecular compound using excited-state intramolecular proton transfer, organic electroluminescent element and laser device using the same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2015-08-11 | — | — | US | disclosed |
| US-9106057-B2 | White-emitting monomolecular compound using excited-state intramolecular proton transfer, organic electroluminescent element and laser device using the same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2015-08-11 | — | — | US | disclosed |
| US-9077155-B2 | White-emitting monomolecular compound using excited-state intramolecular proton transfer, organic electroluminescent element and laser device using the same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2015-07-07 | — | — | US | disclosed |
| US-9077155-B2 | White-emitting monomolecular compound using excited-state intramolecular proton transfer, organic electroluminescent element and laser device using the same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2015-07-07 | — | — | US | disclosed |
| US-9077155-B2 | White-emitting monomolecular compound using excited-state intramolecular proton transfer, organic electroluminescent element and laser device using the same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2015-07-07 | — | — | US | disclosed |
| US-9024036-B2 | White-emitting monomolecular compound using excited-state intramolecular proton transfer, organic electroluminescent element and laser device using the same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2015-05-05 | — | — | US | disclosed |
| US-9024036-B2 | White-emitting monomolecular compound using excited-state intramolecular proton transfer, organic electroluminescent element and laser device using the same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2015-05-05 | — | — | US | disclosed |
| US-9024036-B2 | White-emitting monomolecular compound using excited-state intramolecular proton transfer, organic electroluminescent element and laser device using the same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2015-05-05 | — | — | US | disclosed |
| US-20140329866-A1 | OMEGA-CARBOXYARL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS | BAYER HEALTHCARE LLC (US) | 2014-11-06 | — | — | US | disclosed |
| CN-1341098-A | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | BAYER AG (US) | 2002-03-20 | — | — | CN | disclosed |
| EP-1158985-A1 | OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS | Bayer Corporation (US) | 2001-12-05 | — | — | EP | disclosed |
| US-20010034447-A1 | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | BAYER HEALTHCARE LLC | 2001-10-25 | — | — | US | disclosed |
| EP-1140840-A1 | -G(V)-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS | Bayer Corporation (US) | 2001-10-10 | — | — | EP | disclosed |
| US-20010027202-A1 | Omega-carboxyaryl substituted disphenyl ureas as raf kinase inhibitors | BAYER HEALTHCARE LLC | 2001-10-04 | — | — | US | disclosed |
| US-20010016659-A1 | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | BAYER HEALTHCARE LLC | 2001-08-23 | — | — | US | disclosed |
| US-20010011135-A1 | Omega-carboxyaryl subsituted diphenyl ureas as raf kinase inhibitors | BAYER HEALTHCARE LLC | 2001-08-02 | — | — | US | disclosed |
| US-20010011136-A1 | omega-carboxyyaryl substituted diphenyl ureas as raf kinase inhibitors | BAYER HEALTHCARE LLC | 2001-08-02 | — | — | US | disclosed |
| WO-2000041698-A1 | φ-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS | BAYER CORPORATION (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-2000042012-A1 | φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS | BAYER CORPORATION (US) | 2000-07-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010011135-A1 | Omega-carboxyaryl subsituted diphenyl ureas as raf kinase inhibitors | BRAF, RAF1, ARAF | KDM4E 1572/4885MAPT 2180/4885CYP1A2 1373/4885 |
| US-20010011136-A1 | omega-carboxyyaryl substituted diphenyl ureas as raf kinase inhibitors | BRAF, ARAF, RAF1 | KDM4E 1326/4885MAPT 2754/4885CYP1A2 2741/4885 |
| US-20010034447-A1 | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | BRAF, RAF1, ARAF | KDM4E 1426/4885MAPT 2299/4885CYP1A2 1283/4885 |
| US-20010016659-A1 | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | BRAF, RAF1, ARAF | KDM4E 1426/4885MAPT 2299/4885CYP1A2 1283/4885 |
| US-20140329866-A1 | OMEGA-CARBOXYARL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS | BRAF, RAF1, ARAF | KDM4E 1407/4885MAPT 2474/4885CYP1A2 2705/4885 |
| US-20010027202-A1 | Omega-carboxyaryl substituted disphenyl ureas as raf kinase inhibitors | BRAF, NRAS, ARAF | KDM4E 2089/4885MAPT 2928/4885CYP1A2 1580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.